Drawing for GLYCANOSTICS

USPTO serial 79340032

GLYCANOSTICS

Reviewed by CopyMark Law Group

Reg. 7159631Status 700Registered
Filing date
Status date
Registration date
Sep 12, 2023
Examiner
BLAKESLEE, RICHARD A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GLYCANOSTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rhett V. Barney

Rhett V. Barney Lee & Hayes, PC601 W. Riverside Ave. Suite 1400Spokane, WA 99201UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005chemical preparations for pharmaceutical purposes, namely, for calibration of diagnostics tests in a form of a glycoprotein standard; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for diagnosis of oncological diseases, autoimmune diseases and neurological diseases; stem cells for medical purposes; biological tissue cultures for medical purposes; diagnostic biomarker reagents for medical purposes; medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseasesACTIVE—
010Blood testing apparatus; testing apparatus for medical purposes for testing glycans in the nature of complex carbohydrates and sugars attached to proteins and lipids; diagnostic apparatus for medical purposes for testing glycans in the nature of complex carbohydrates and sugars attached to proteins and lipidsACTIVE—
035Retail store services for pharmaceutical preparations, chemical preparations for pharmaceutical purposes, diagnostic preparations for medical purposes, chemical preparations for medical purposes, stem cells for medical purposes, biological tissue cultures for medical purposes, diagnostic biomarker reagents for medical purposes, blood testing apparatus, testing apparatus for medical purposes, diagnostic apparatus for medical purposes, medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases; online retail store services for pharmaceutical preparations, chemical preparations for pharmaceutical purposes, diagnostic preparations for medical purposes, chemical preparations for medical purposes, stem cells for medical purposes, biological tissue cultures for medical purposes, diagnostic biomarker reagents for medical purposes, blood testing apparatus, testing apparatus for medical purposes, diagnostic apparatus for medical purposes, medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseasesACTIVE—
040Custom manufacture of medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseasesACTIVE—
041Educational services in the nature of academies, namely, conducting seminars, workshops, lectures, practical experimental demonstrations in the field of glycomics, biomarker discovery, disease diagnostics, proteomics, life science company development; arranging and conducting of colloquiums in the field of glycomics, biomarker discovery, disease diagnostics, proteomics, life science company development; arranging and conducting of conferences in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of congresses in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of seminars in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of symposiums in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of in-person educational forums in the field of glycomics, biomarker discovery, disease diagnostics, proteomicsACTIVE—
042Chemical analysis; chemical research; biological research; scientific laboratory services; scientific research; medical and scientific research, namely, conducting clinical validations trials for diagnostic and pharmaceutical companies; medical researchACTIVE—
044Medical services; pharmacy advice, namely, pharmaceutical advice for diagnostic and pharmaceutical companies; health counselling; medical analysis services for diagnostic and treatment purposes provided by medical laboratoriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 8, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 14, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 14, 2023FIMPFINAL DISPOSITION PROCESSED—
Dec 12, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 12, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 12, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 27, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 27, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jun 8, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 7, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 7, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 23, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 24, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 24, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 24, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 12, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Mar 12, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 12, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 27, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 26, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 26, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 13, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 13, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 13, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 13, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 13, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 4, 2023RFNPREFUSAL PROCESSED BY IB—
Dec 10, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 9, 2022RFRRREFUSAL PROCESSED BY MPU—
Sep 29, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 28, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2022DOCKASSIGNED TO EXAMINER—
Jul 1, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 17, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
May 13, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 12, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance